The key players in cancer collaborations include academic institutions, pharmaceutical companies, non-profit organizations, and government agencies. Academic institutions contribute through fundamental research and clinical trials. Pharmaceutical companies bring in the expertise for drug development and commercialization. Non-profit organizations often provide funding and advocate for patient-centric research, while government agencies such as the National Cancer Institute (NCI) set guidelines and provide significant funding for research initiatives.
